AKASA
Generative AI for coding and revenue cycle operations
Our take
AKASA builds generative AI for the mid-revenue cycle, principally medical coding and clinical documentation integrity, for hospitals and health systems. Its LLM-based products read full clinical context in the chart to suggest codes, flag documentation gaps, and automate follow-up work like prior auth and claims status, connecting to Epic and Oracle Health through FHIR and HL7 rather than screen-scraping.
Formerly Alpha Health, the company has raised $205M from Andreessen Horowitz, BOND, Coatue, and others, making it one of the best-capitalized pure RCM AI vendors. Its defining relationship is Cleveland Clinic: a 2025 strategic collaboration to co-develop revenue cycle AI that expanded in October 2025 into a system-wide US rollout of AKASA's CDI product. The company says its technology touches 650+ hospitals and 6,500 outpatient facilities representing over $120B in net patient revenue, with Duke University Health System among named customers.
What it does
- Generative AI medical coding trained on clinical documentation
- Clinical documentation integrity (CDI) review at scale
- Automates prior auth status and claims follow-up work
- LLMs fine-tuned on customer clinical and financial data
- Surfaces missed codes and documentation gaps pre-bill
Where it's strong
- Cleveland Clinic co-developed and is now deploying its GenAI CDI product across all US locations, a rare tier-one clinical validation.
- Deep pockets ($205M raised) and deployment across 650+ hospitals reduce vendor-viability risk.
- Focus on mid-revenue-cycle (coding plus CDI) fits health systems that want one vendor for both.
What buyers should weigh
- The company pivoted from RPA-style automation to generative AI, so ask which product generation you are actually buying.
- Flagship proof points are large academic systems; fit and pricing for smaller hospitals is less proven.
- Last disclosed raise was 2022, so probe current burn and roadmap funding.
Latest
In October 2025 Cleveland Clinic expanded its AKASA partnership to deploy the GenAI-powered CDI solution across all its US locations after completing the first pilot, and Black Book ranked AKASA the most promising healthcare RCM startup of 2025.
Also in Autonomous Medical Coding
CodaMetrix
Autonomous coding spun out of Mass General Brigham
Nym
Explainable autonomous coding for ED and outpatient
Fathom
High-volume autonomous coding across specialties
Arintra
Autonomous medical coding that runs inside your EHR
Solventum (formerly 3M Health Information Systems)
The incumbent coding and CDI platform, adding autonomous coding
Maverick AI
Real-time autonomous medical coding for revenue cycle teams
RapidClaims
Autonomous AI coding and claim scrubbing across the revenue cycle
Track this market
First Pass covers Autonomous Medical Coding and the rest of the getting-paid stack every week.